Skip to main content
SpringerLink
Log in

On the relevance of ischemic preconditioning in humans

  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Conclusion

In conclusion, existing data in animals and in man give us no reason to doubt that ischemic preconditioning can and will occur in patients. The clinical implication of endogenous protection will be difficult to determine because of large variability in the preceding pathological conditions and our inability to determine infarct size and its major determinants accurately in man. In addition, myocardium may not only be preconditioned by ischemia but may also become resistant. However, the existing evidence suggests that some pharmacological agents not only lower the threshold for ischemic preconditioning, but are still effective when myocardium has become resistant to ischemic preconditioning. These agents could be useful in patients at risk of infarction provided that the myocardium does not become resistant to continued use of these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cohen MV, Yang XM, Downey JM (1994) Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74: 998–1004

    Google Scholar 

  2. Gho BCG, Schoemaker RG, Doel MA van den, Duncker DJ, Verdouw PD (1996) Myocardial protection by brief ischemia in non-cardiac tissue. Circulation 94: (9): 2193–2200

    Google Scholar 

  3. Kapadia SJ, Terlato JS, Most, AS (1997) Presence of a critical coronary artery stenosis does not abolish the protective effect of ischemic preconditioning. Circulation 95: 1286–1292

    Google Scholar 

  4. Koning MMG, Gho BCG, Van Klaarwater E, Duncker DJ, Verdouw PD (1995) Endocardial and epicardial infarct size after preconditioning by a partial coronary artery occlusion without intermittent reperfusion. Importance of the degree and duration of flow reduction. Cardiovasc Res 30: 1017–1027

    Google Scholar 

  5. Koning MMG, Gho BCG, Van Klaarwater E, Opstal RLJ, Duncker DJ, Verdouw PD (1996) Rapid ventricular pacing produces myocardial protection by non-ischemic activation of KATP + channels. Circulation 93: 178–186

    Google Scholar 

  6. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R (1997) Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 95: 2500–2507

    Google Scholar 

  7. Liu Y, Gao WD, O'Rourke B, Marban E (1996) Cell-type specificity of preconditioning in an in vitro model. Basic Res Cardiol 91: 450–457

    Google Scholar 

  8. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 75: 1124–1136

    Google Scholar 

  9. Ovize M, Kloner RA, Przyklenk K (1994) Stretch preconditions canine myocardium. Am J Physiol 266: H137-H146

    Google Scholar 

  10. Ovize M, Przyklenk K, Kloner RA (1992) Partial coronary stenosis is sufficient and complete reperfusion is mandatory for preconditioning the canine heart. Circ Res 71: 1165–1173

    Google Scholar 

  11. Rohmann S, Schelling P, Verdouw PD (1996) Renewal of ischemic preconditioning's protection is possible by activation of ATP-sensitive potassium (KATP) channels (abstract). Circulation 94 (8): I364

    Google Scholar 

  12. Schulz R, Post H, Sakka S, Wallbridge DR, Heusch G (1995) Intraischemic preconditioning: increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. Circulation 76: 942–950

    Google Scholar 

  13. Speechly-Dick ME, Baxter GF, Yellon DM (1994) Ischaemic preconditioning protects hypertrophied myocardium. Cardiovase Res 28: 1025–1029

    Google Scholar 

  14. Tani M, Suganuma Y, Hasegawa H, Shimura K, Hayashi Y, Guo X, Nakamura Y (1997) Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 95: 2559–2566

    Google Scholar 

  15. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, Chiariello L, Gioffre PA (1994) Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 90: 700–705

    Google Scholar 

  16. Verdouw PD, Gho BCG, Duncker DJ (1995) Ischemic preconditioning: is it clinically relevant? Eur hear J 16: 1169–1176

    Google Scholar 

  17. Yao Z, Gross GJ (1994) Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol 267: H1888-H1894

    Google Scholar 

  18. Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. Lancet 342: 276–277

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Cardiology, Thoraxcenter, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands

    P. D. Verdouw, M. A. van den Doel, S. de Zeeuw & D. J. Duncker

Authors
  1. P. D. Verdouw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. van den Doel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. de Zeeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Duncker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verdouw, P.D., van den Doel, M.A., de Zeeuw, S. et al. On the relevance of ischemic preconditioning in humans. Basic Res Cardiol 92 (Suppl 2), 51–53 (1997). https://doi.org/10.1007/BF00797210

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00797210

Keywords

Search

Navigation